Top 8 manufacturers in C-C Chemokine Receptor Type 4 Market
By Prof Researh
Updated 12:00:26 January 18, 2020
.
Updated 12:00:26 January 18, 2020
Prof Resear published a new Market report on C-C Chemokine Receptor Type 4 Market. It present the largest 8 manufacruers in C-C Chemokine Receptor Type 4 Market. The report is a professional and in-depth study on the current state of the global C-C Chemokine Receptor Type 4 market with a focus on the Chinese market. The report provides key statistics on market of C-C Chemokine Receptor Type 4. It is a valuable source of guidance and direction for companies and individuals interested in C-C Chemokine Receptor Type 4 industry.
.
Affitech A/S
Ref A: 4B60804E340049AFA72A022FC47A3D99 Ref B: SJCEDGE0414 Ref C: 2020-01-18T04:00:03Z
AstraZeneca Plc
Ref A: 58C1E4CFFFF14AAC9915329AD7CACD77 Ref B: SJCEDGE0412 Ref C: 2020-01-18T04:00:05Z
ChemoCentryx Inc
Description ChemoCentryx , Inc ., a clinical-stage biopharmaceutical company , develops new medications for inflammatory and autoimmune diseases, and cancer in the United States. The company … Nov 06, 2019 · ChemoCentryx , Inc . is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and … ChemoCentryx , Inc . operates as a biopharmaceutical company . The Company researches orally-administered small-molecule therapies for inflammatory diseases.
Corion Biotech Srl
Ref A: DC883EFF423D4DE1A2AD141AA2E91C93 Ref B: SJCEDGE0211 Ref C: 2020-01-18T04:00:08Z
FLX Bio Inc
FLX Bio , Inc . operates as a privately-held biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of novel immuno-oncology agents. Find revenue, contact and employee information for FLX Bio Inc . Dirk G Brockstedt is Senior VP:Biology at FLX Bio Inc . See Dirk G Brockstedts compensation, career history, education, & memberships.
Globavir Biosciences Inc
Ref A: B4D47BDC835B476B8E9DE48188D23F32 Ref B: SJCEDGE0415 Ref C: 2020-01-18T04:00:23Z
Kyowa Hakko Kirin Co Ltd
Ref A: A392DB2FC32F4F208313683314481266 Ref B: SJCEDGE0222 Ref C: 2020-01-18T04:00:25Z
Ono Pharmaceutical Co Ltd
Ref A: D34DB8176EE342A89A0A11EDEFA890AE Ref B: SJCEDGE0417 Ref C: 2020-01-18T04:00:26Z